Patents by Inventor Omar M. Lattouf
Omar M. Lattouf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11737769Abstract: Methods and devices for catheter-based removal of unwanted tissue or occlusive matter from blood vessels and other body lumens rely on a wire advanced from a tube to deploy a capture net that can be drawn over the clot. Apparatus include simple and reliable mechanisms for deployment of nets, funnels, and other clot capturing mechanisms for retrieving clot material from inside a blood vessel.Type: GrantFiled: May 13, 2019Date of Patent: August 29, 2023Inventor: Omar M. Lattouf
-
Publication number: 20200029983Abstract: Methods and devices for catheter-based removal of unwanted tissue or occlusive matter from blood vessels and other body lumens rely on a wire advanced from a tube to deploy a capture net that can be drawn over the clot. Apparatus include simple and reliable mechanisms for deployment of nets, funnels, and other clot capturing mechanisms for retrieving clot material from inside a blood vessel.Type: ApplicationFiled: May 13, 2019Publication date: January 30, 2020Inventor: Omar M. Lattouf
-
Patent number: 10456260Abstract: Two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, may be performed separately or together. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. Improved devices for these procedures include a minimally invasive grasping device for heart leaflets, a leaflet connector with artificial cordae tendenae and a pacing lead implant instrument.Type: GrantFiled: February 7, 2019Date of Patent: October 29, 2019Assignee: Trans Cardiac Therapeutics, Inc.Inventor: Omar M. Lattouf
-
Publication number: 20190209325Abstract: Two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, may be performed separately or together. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. Improved devices for these procedures include a minimally invasive grasping device for heart leaflets, a leaflet connector with artificial cordae tendenae and a pacing lead implant instrument.Type: ApplicationFiled: February 7, 2019Publication date: July 11, 2019Applicant: Trans Cardiac Therapeutics, Inc.Inventor: Omar M. Lattouf
-
Publication number: 20180263659Abstract: Two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, may be performed separately or together. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. Improved devices for these procedures include a minimally invasive grasping device for heart leaflets, a leaflet connector with artificial cordae tendenae and a pacing lead implant instrument.Type: ApplicationFiled: May 21, 2018Publication date: September 20, 2018Applicant: Trans Cardiac Therapeutics, Inc.Inventor: Omar M. Lattouf
-
Patent number: 9999442Abstract: Two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, may be performed separately or together. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. Improved devices for these procedures include a minimally invasive grasping device for heart leaflets, a leaflet connector with artificial cordae tendenae and a pacing lead implant instrument.Type: GrantFiled: April 26, 2013Date of Patent: June 19, 2018Assignee: Trans Cardiac Therapeutics, Inc.Inventor: Omar M. Lattouf
-
Publication number: 20130253641Abstract: Two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, may be performed separately or together. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. Improved devices for these procedures include a minimally invasive grasping device for heart leaflets, a leaflet connector with artificial cordae tendenae and a pacing lead implant instrument.Type: ApplicationFiled: April 26, 2013Publication date: September 26, 2013Applicant: Trans Cardiac Therapeutics, Inc.Inventor: Omar M. Lattouf
-
Publication number: 20120203072Abstract: The invention is directed to a method of treating a patient's heart. In this method an instrument port is secured within a passageway through a wall of an apical region of the patient's heart to allow the passage of a treatment instrument.Type: ApplicationFiled: September 28, 2011Publication date: August 9, 2012Inventors: Omar M. Lattouf, Dirk Hoyns, Larry Hall, Amin Rahme
-
Patent number: 8029565Abstract: The invention is directed to two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, and devices and systems for such procedures. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.Type: GrantFiled: April 2, 2009Date of Patent: October 4, 2011Inventor: Omar M. Lattouf
-
Publication number: 20110144743Abstract: The invention is directed to two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, and devices and systems for such procedures. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.Type: ApplicationFiled: February 23, 2011Publication date: June 16, 2011Applicant: Transcardiac Therapeutics, Inc.Inventor: Omar M. Lattouf
-
Patent number: 7871433Abstract: The invention is directed to two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, and devices and systems for such procedures. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.Type: GrantFiled: February 20, 2008Date of Patent: January 18, 2011Inventor: Omar M. Lattouf
-
Publication number: 20090192598Abstract: The invention is directed to two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, and devices and systems for such procedures. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.Type: ApplicationFiled: April 2, 2009Publication date: July 30, 2009Inventor: Omar M. Lattouf
-
Patent number: 7534260Abstract: The invention is directed to a minimally invasive therapeutic procedure, particularly for patients with congestive heart failure, and devices and systems for such procedures. this procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. Improved devices for this procedure include a minimally invasive grasping device having an inner lumen for advancing connecting members and other instruments through the device to the distal end thereof. Other improved instruments include a leaflet connector with an artificial cordae tendenae strand secured to an end of the leaflet connector.Type: GrantFiled: November 22, 2005Date of Patent: May 19, 2009Inventor: Omar M. Lattouf
-
Patent number: 7513908Abstract: The invention is directed to two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, and devices and systems for such procedures. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.Type: GrantFiled: November 22, 2005Date of Patent: April 7, 2009Inventor: Omar M. Lattouf
-
Publication number: 20080249504Abstract: Instrument port for allowing access to the interior of the heart or other organ while minimizing blood loss.Type: ApplicationFiled: January 8, 2008Publication date: October 9, 2008Inventors: Omar M. Lattouf, Dirk Hoyns, Larry Hall, Amin Rahme
-
Publication number: 20080147184Abstract: The invention is directed to two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, and devices and systems for such procedures. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.Type: ApplicationFiled: February 20, 2008Publication date: June 19, 2008Inventor: Omar M. Lattouf
-
Patent number: 7373207Abstract: The invention is directed to devices for two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure. One procedure involves providing a valve to form a passageway through the patient's left ventricular wall at the apex of the patient's heart and configured to advance instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve, in a “Bow-Tie” configuration to prevent or minimize regurgitation through the valve. The second procedure is directed to a pacing lead with a housing and a pacing lead implanting device which are configured to pass through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. One or both procedures may be performed on a patient with CHF.Type: GrantFiled: December 6, 2002Date of Patent: May 13, 2008Inventor: Omar M. Lattouf
-
Patent number: 6978176Abstract: Two minimally invasive therapeutic procedures, particularly for patients with congestive heart failure, may be performed separately or together. One procedure involves providing a valved passageway through the patient's left ventricular wall at the apex of the patient's heart and advancing instruments through the valved passageway to connect the valve leaflets of the patient's heart valve, e.g. the mitral valve. The second procedure involves advancing a pacing lead and a pacing lead implanting device through a trocar in the patient's chest and implanting the pacing lead on an exposed epicardial region of the patient's heart wall. The pacing lead has a penetrating electrode which is secured within the heart wall. Improved devices for these procedures include a minimally invasive grasping device for heart leaflets, a leaflet connector with artificial cordae tendenae and a pacing lead implant instrument.Type: GrantFiled: November 15, 2002Date of Patent: December 20, 2005Inventor: Omar M. Lattouf
-
Publication number: 20040116963Abstract: Needle-suture combinations are disclosed that include two surgical needles, each including an end having a suture-receiving aperture, and two sutures attached to the ends of each of the two needles. Also disclosed are methods for using the needle-suture combination, the method including passing through a first tissue and a second tissue two needle-suture combinations each having first and second needles connected to first and second sutures; pulling the sutures therethrough; disconnecting the needles from the sutures, thereby providing free ends on the sutures; tying the free ends of the first sutures of the first needle-suture combination together; and tying the free end of the second suture of the first needle-suture combination with the second suture of the second needle-suture combination. With the apparatus and/or method, elements joined together may form a more hemostatic seal.Type: ApplicationFiled: September 26, 2003Publication date: June 17, 2004Inventor: Omar M Lattouf
-
Publication number: 20030212304Abstract: Disclosed are systems and methods for performing counter-cardiac retrograde perfusion. Perfusion is performed in a counter-cardiac cycle such that oxygenated blood is urged through a patient vein associated with an organ to be provided with the blood during diastole only.Type: ApplicationFiled: March 14, 2003Publication date: November 13, 2003Inventor: Omar M. Lattouf